Program
desloratadine
Also written as “Desloratadine”, “Desloratadine 5 mg” and “Desloratadine 5 mg (Clarinex)”.
Its studies are mostly in Rhinitis, Allergic, Seasonal · Rhinitis, Allergic · Urticaria · Hypersensitivity · Chronic Urticaria, led by 6 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Organon | 270 open or running | phase 4since Apr 4, 2006 | Apr 4, 2006 | none ahead |
| Dr. Reddy's Laboratories | 60 open or running | phase 1since Mar 11, 2011 | Mar 11, 2011 | none ahead |
| EMS | 30 open or running | phase 3since Feb 6, 2012 | Feb 6, 2012 | none ahead |
| Ache Laboratorios Farmaceuticos | 10 open or running | phase 3since Mar 8, 2016 | Mar 8, 2016 | none ahead |
| Eurofarma Laboratorios | 10 open or running | phase 3since Dec 13, 2021 | Dec 13, 2021 | none ahead |
| Laboratorios Silanes S.A. de C.V. | 10 open or running | phase 3since Apr 1, 2025 | Apr 1, 2025 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 20 studies since Apr 4, 2006.
- Jan 5, 2009Phase 3 study in Dermatitis, AtopicOrganon · NCT00817076 · 40 enrolled
- Jan 5, 2009Phase 2 study in Rhinitis, Allergic, SeasonalOrganon · NCT00816972 · 540 enrolled
- Mar 20, 2009Phase 4 study in Rhinitis, Allergic, SeasonalOrganon · NCT00867191 · 233 enrolled
- Mar 11, 2011Dr. Reddy's Laboratories's first studies: 2 phase 1 studiesNew to Dr. Reddy's LaboratoriesDr. Reddy's Laboratories · NCT01314352, NCT01314339
- Jun 10, 2011Phase 1 study in HealthyDr. Reddy's Laboratories · NCT01373138 · 34 enrolled · Canada
- Sep 27, 2011Phase 1 study in HealthyDr. Reddy's Laboratories · NCT01506791 · 44 enrolled · United States
- Jan 5, 20122 phase 1 studies in HealthyDr. Reddy's Laboratories · NCT01506050, NCT01506037
- Feb 6, 2012EMS's first studies: 2 phase 3 studiesNew to EMSEMS · NCT01529242, NCT01529229
- Oct 31, 2012Phase 3 study in Rhinitis, AllergicEMS · NCT01720485 · 234 enrolled · Brazil
- Aug 2, 20133 phase 3 studiesOrganon · NCT01916980, NCT01916967, NCT01918033
- Dec 15, 2014Phase 3 study in Rhinitis, Allergic, SeasonalOrganon · NCT02320396 · 449 enrolled
- Mar 8, 2016Ache Laboratorios Farmaceuticos's first study: phase 3 study in Common ColdNew to Ache Laboratorios FarmaceuticosAche Laboratorios Farmaceuticos · NCT02904304 · 150 enrolled · Brazil
- Dec 13, 2021Eurofarma Laboratorios's first study: phase 3 study in Rhinitis, AllergicNew to Eurofarma LaboratoriosEurofarma Laboratorios · NCT05214911 · 262 enrolled · Brazil
- Apr 1, 2025Laboratorios Silanes S.A. de C.V.'s first study: phase 3 study in Rhinitis, AllergicNew to Laboratorios Silanes S.A. de C.V.Laboratorios Silanes S.A. de C.V. · NCT06916884 · 70 enrolled · Mexico
TargetBeta
“Histamine H1 receptor antagonist”ChEMBL 37, by rule
Other programs on HRH1
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| fexofenadinerule | Sanofi | phase 4 | 38 |
| bilastinerule | faes-farma-s-a | phase 4 | 19 |
| Diphenhydraminerule | Johnson & Johnson | phase 4 | 16 |
Studies
All 39 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT06916884Rhinitis, Allergic · Mexico | 3 | Completed | Laboratorios Silanes S.A. de C.V. | Oct 15, 2025 | 70 |
| NCT05214911Rhinitis, Allergic · Brazil | 3 | Completed | Eurofarma Laboratorios | Mar 23, 2025 | 262 |
| NCT02904304Common Cold · Brazil | 3 | Suspended | Ache Laboratorios Farmaceuticos | Jul 2021 | 150 |
| NCT02320396Rhinitis, Allergic, Seasonal | 3 | Completed | Organon | Apr 27, 2015 | 449 |
| NCT01918033Rhinitis, Allergic, Perennial | 3 | Completed | Organon | Jan 26, 2014 | 608 |
| NCT01916980Eczema | 3 | Completed | Organon | Mar 8, 2014 | 94 |
| NCT01916967Urticaria | 3 | Completed | Organon | Feb 28, 2014 | 239 |
| NCT01720485Rhinitis, Allergic · Brazil | 3 | UNKNOWN | EMS | Dec 2013 | 234 |
| NCT01529242Cutaneous Hypersensitivity · Brazil | 3 | Terminated | EMS | Aug 2016 | 17 |
| NCT01529229Rhinitis, Allergic | 3 | Completed | EMS | Oct 2014 | 210 |
| NCT01506050Healthy · United States | 1 | Completed | Dr. Reddy's Laboratories | 35 | |
| NCT01506037Healthy · United States | 1 | Completed | Dr. Reddy's Laboratories | 36 | |
| NCT01506791Healthy · United States | 1 | Completed | Dr. Reddy's Laboratories | 44 | |
| NCT01373138Healthy · Canada | 1 | Completed | Dr. Reddy's Laboratories | 34 | |
| NCT01314352Lecithin Cholesterol Acyltransferase Deficiency · United States | 1 | Completed | Dr. Reddy's Laboratories | Dec 2005 | 28 |
| NCT01314339Fasting · United States | 1 | Completed | Dr. Reddy's Laboratories | Dec 2005 | 28 |
| NCT00867191Rhinitis, Allergic, Seasonal | 4 | Completed | Organon | Apr 1, 2003 | 233 |
| NCT00817076Dermatitis, Atopic | 3 | Completed | Organon | Jul 2003 | 40 |
| NCT00816972Rhinitis, Allergic, Seasonal | 2 | Completed | Organon | Jun 2005 | 540 |
| NCT00805584Rhinitis, Allergic, Seasonal | 4 | Completed | Organon | Jun 2003 | 311 |
| NCT00805324Rhinitis, Allergic, Seasonal | 3 | Completed | Organon | Aug 2003 | 54 |
| NCT00795158Urticaria | 3 | Completed | Organon | Jan 2004 | 282 |
| NCT00795522Urticaria | 4 | Completed | Organon | Feb 2005 | 51 |
| NCT00794846Rhinitis, Allergic, Seasonal | 4 | Completed | Organon | May 2003 | 124 |
| NCT00794794Rhinitis, Allergic | 3 | Completed | Organon | Nov 2004 | 204 |
| NCT00794599Rhinitis, Allergic, Seasonal | 4 | Completed | Organon | Aug 2003 | 118 |
| NCT00794495Rhinitis, Allergic, Seasonal | 4 | Completed | Organon | Jul 2003 | 122 |
| NCT00794378Rhinitis, Allergic | 3 | Completed | Organon | Nov 2004 | 202 |
| NCT00783354Urticaria | 4 | Completed | Organon | Feb 1, 2004 | 129 |
| NCT00783211Rhinitis, Allergic, Seasonal | 4 | Completed | Organon | Oct 1, 2004 | 722 |
| NCT00783146Rhinitis, Allergic, Seasonal | 4 | Completed | Organon | Oct 1, 2004 | 728 |
| NCT00780403Hypersensitivity | 4 | Completed | Organon | Oct 2005 | 220 |
| NCT00779636Allergic Airway Disease | 4 | Completed | Organon | Nov 1, 2004 | 506 |
| NCT00779116Hypersensitivity | 4 | Completed | Organon | Oct 2005 | 217 |
| NCT00757562Chronic Urticaria | 3 | Completed | Organon | Oct 1, 2003 | 97 |
| NCT00751218Urticaria | 4 | Completed | Organon | May 24, 2005 | 174 |
| NCT00751166Urticaria | 4 | Terminated | Organon | May 1, 2005 | 149 |
| NCT00359138Hypersensitivity | 4 | Completed | Organon | May 2006 | 36 |
| NCT00311844Conjunctivitis, Allergic | 4 | Completed | Organon | May 28, 2005 | 41 |
How it is read
Names in the registry
- “Desloratadine”, 12 entries
- “desloratadine”, 11 entries
- “Desloratadine 5 mg”, 3 entries
- “Desloratadine 5 mg (Clarinex)”, 3 entries
- “Desloratadine + Prednisolone”, 3 entries
Conditions, from the studies’ own filings
- Rhinitis, Allergic, Seasonal, 10 studies
- Rhinitis, Allergic, 6 studies
- Urticaria, 5 studies
- Hypersensitivity, 3 studies
- Chronic Urticaria, 2 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.